Category Archives: oud

Cerner Replaces Siemens Software With Its Millennium At Universal

One way to win a big contract is to persuade existing customers to buy your companion products. Another way to win is to buy your rival and sell your products to your ex-rival’s customers. Cerner ( CERN ), one of the largest makers of software for the health care industry, did it both ways when it persuaded the second-largest publicly traded hospital chain in the U.S., Universal Health Services ( UHS ), to upgrade from its Siemens ( SIEGY ) Invision revenue-cycle software to Cerner’s new Millennium Revenue Cycle suite. First, Cerner took out the competitor, Siemens Health Services, for $1.3 billion in February 2015. Then it went to work on Siemens’ revenue-cycle client Universal Health, which was already a Cerner customer in that it used Cerner’s  electronic health records (EHR) and health information management (HIM) software on the clinical side of the medical profession. But for the business side — to handle patient eligibility, co-pays, coding claims, tracking, collections and following up on claim denials — Universal Health was using Siemens’ Invision. Cerner’s new Millennium Revenue Cycle product handles both the medical and business sides, while integrating with the federal government’s push toward electronic health records (EHR) and PopHealth analytics to inform medical and administrative decision makers, as well as regulators and policymakers. “The size of the deal is unknown, and considering UHS is switching from one CERN-owned platform (Siemens’ Invision) to the core CERN Millennium platform, the contribution will not be as large as if it were a completely new customer,” said Canaccord Genuity analyst Richard Close in a research note Thursday. Hey, money isn’t everything. “Just as important as the size of the deal, however, is the signature nature of the Siemens conversion to Millennium Revenue Cycle for Cerner,” said RBC Capital Markets analyst David Francis in a Thursday research note. “While the clinical side of Cerner’s Millennium offering has been highly regarded for some time, there have been pockets of questions recently about Cerner’s revenue-cycle capabilities for large enterprises. “The UHS decision to replace Invision … is a major conversion and should help Cerner in convincing other Siemens financial users to strongly consider not only moving their clinical platform to Millennium, but their financial solution as well.” Cerner announced the Universal Health deal after Wednesday’s market close. In the stock market today , Cerner shares rose 1.4% to a two-month high of 55.98, 26% off an all-time high of 75.72 set nearly a year earlier, April 13, and down 12% for the year. Universal Health stock fell 1% to 123.04, 17% off  its record high of 148.57, set Aug. 5.

Why You Should Watch FB, GOOGL, AMZN Ahead Of Earnings

Loading the player… Three top tech stocks are trading very near buy points as handles have formed on their bases: Facebook ( FB ), Google owner Alphabet ( GOOGL ) and Amazon ( AMZN ). And with each company reporting earnings in the coming weeks, these stocks deserve a watchful eye. JPMorgan noted Thursday that while FANG stocks (Facebook, Amazon, Netflix ( NFLX ) and Google/Alphabet) have somewhat underperformed so far this year, their fundamentals are still solid. After rising nearly 18% from its February low, Facebook was trading 3% below a 117.09 buy point Thursday as it dipped less than 0.1%. If and when the stock breaks out, look for heavy volume, which signals institutional support. A catalyst for a Facebook breakout could be the company’s quarterly earnings report on April 27. Earnings are projected to jump 48%, marking a third straight quarter of faster growth. Revenue is also expected to rise 48%, a slowdown from the prior quarter’s 52% growth. Alphabet was trading 2% below a cup-with-handle buy point of 777.41, and closed down 1%. It’s 6% below its high reached in early February. Alphabet reports quarterly results on April 21. Analysts expect earnings growth of 23%, slower than the last quarter’s 28% gain. Revenue is estimated to climb 17%, slightly slower than the 18% gain it saw in Q4. Facebook and Alphabet are both members of the IBD 50 list of leading stocks and earn a highest-possible IBD Composite Rating of 99. Amazon has an 81 Composite Rating. The stock is trading 2% below a 603.34 buy point and 15% below its late December high. Shares fell 1.8% Thursday. The e-commerce giant’s bottom line is projected to skyrocket 583% when it issues its quarterly report in a couple of weeks. That would mark a second quarter of accelerating growth. The top line is estimated to climb 23%, faster than Q4’s 22% rise. Meanwhile, the fourth FANG stock, Netflix, is trading more than 20% below its high set in early December. Shares, which have been hitting resistance at the critical 200-day moving average, dipped 0.4% Thursday. Netflix reports its quarterly results on April 18.